• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LTD. - HUNTINGTON ACRYSOF MULTIPIECE IOL; INTRAOCULAR LENS Back to Search Results
Model Number MA60BM
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Visual Impairment (2138)
Event Type  Injury  
Manufacturer Narrative
Evaluation summary: the product was not returned for analysis.The complaint history and product history records could not be reviewed because the reporting facility did not provide a lot number or any identification traceable to the manufacturing documentation.The product investigation could not identify a root cause.(b)(4).
 
Event Description
An ophthalmologist reported that in a literature article abstract titled decreased visual acuity resulting from glistening and sub-surface nano-glistening formation in intraocular lenses: a retrospective analysis of 5 cases.According to the authors, there were 5 patients whose visual acuity improved when the intraocular lenses (iols) were exchanged because of severe glistening and subsurface nano-glistening (ssng).All affected iols had been originally implanted over a range of 6-15 years prior to the iol exchange.Light transmission was decreased in all affected lenses compared to similar control iol.The authors concluded that although only a few reports of cases in which glistening and ssng have progressed to the level of decreased visual function have been published, the likelihood is that this phenomena will increase as the severity and incidence of these inclusions have been shown to increase with time.Appropriate evaluations of visual function in such patients are needed and consideration should be given to iol exchange in symptomatic patients.No further information is expected.
 
Manufacturer Narrative
Corrected information - literature article abstract attached.(b)(4).
 
Manufacturer Narrative
It was identified the value of was transmitted as null.This supplement is being filed to correct the value from null to adverse event and product problem.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF MULTIPIECE IOL
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
bryan blake
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key7674700
MDR Text Key113578139
Report Number1119421-2018-00897
Device Sequence Number1
Product Code HQL
Combination Product (y/n)N
Reporter Country CodeBB
PMA/PMN Number
P930014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Home Health Aide
Type of Report Initial,Followup,Followup
Report Date 11/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMA60BM
Device Catalogue NumberMA60BM.XXX
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/12/2018
Initial Date FDA Received07/10/2018
Supplement Dates Manufacturer Received07/12/2018
10/29/2018
Supplement Dates FDA Received07/17/2018
11/12/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-